Dermatology · Caguas, PR
NPI
1154543221
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
200 Grand Boulevard Los Prados, Plaza Los Prados Suite Z-5
Caguas, PR, 00727
Phone (787) 746-3136
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,776
76 services
Medicare patients, 2024
30
Average age 75
Drug cost, 2024
$1.5M
2,225 prescriptions
Company payments, 2025
$42K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel Sanchez Rivera was code 99213 (office e&m - established), 33 times for 24 patients. In total Samuel Sanchez Rivera billed 76 services in 14 codes, and Medicare paid $3,776.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 33 | 24 | $58.29 | $1,924 |
By year: 2022 $4,959 for 106 services; 2023 $5,908 for 132 services; 2024 $3,776 for 76 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel Sanchez Rivera prescribed most often to Medicare patients was Ketoconazole, with 536 prescriptions and refills. In total Samuel Sanchez Rivera wrote 2,225 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 536 | 538 | 191 | $12K |
| Betamethasone Valerate Generic | 295 | 296 | 153 | $12K |
| Ciclopirox Generic | 218 | 219 | 86 | $9,951 |
| Ciclopirox Ciclopirox Olamine | 179 | 180 | 83 | $6,787 |
| Triamcinolone Acetonide Generic | 136 | 136 | 64 | $1,704 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 120 | 120 | 62 | $6,986 |
| Desonide Generic | 99 | 99 | 53 | $3,328 |
| Metronidazole Generic | 80 | 80 | 42 | $4,312 |
| Clobetasol Propionate Generic | 64 | 64 | 36 | $3,958 |
| Hydrocortisone Generic | 47 | 47 | 26 | $316 |
| Fluorouracil Generic | 44 | 49 | 27 | $3,454 |
| Mometasone Furoate Generic | 41 | 41 | 24 | $1,023 |
| Clindamycin Phosphate Generic | 28 | 28 | Under 11 | $1,640 |
| Tremfya Guselkumab | 26 | 49 | Under 11 | $356K |
| Taltz Autoinjector Ixekizumab | 25 | 25 | Under 11 | $168K |
Brand drugs: 429 claims; generic drugs: 1,796 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel Sanchez Rivera $42K ($418 in general payments such as food, travel and fees and $41K for research) from 7 companies. The largest payer was Sanofi US Services Inc. with $18K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.